Peptide Therapy
LQV Branded Vial
Tirzepatide
Peptide Therapy
Tirzepatide
From $399|
Provider Approved
Rx RequiredTirzepatide is a dual GIP/GLP-1 receptor agonist that targets two incretin pathways simultaneously. It has demonstrated significant efficacy in clinical weight loss trials and offers enhanced metabolic benefits compared to single-receptor therapies.
Key Benefits
Dual-receptor action for enhanced weight loss
Superior appetite suppression compared to single-agonist therapies
Improved insulin sensitivity and blood sugar control
Reduction in visceral fat
Favorable metabolic profile improvements
1
Total$399.00
Medically directedShips nationwide
Prescription therapies require medical evaluation and supervision. Results vary. Side effects and risks are discussed during consultation.